文献速递甲状腺疾病

低/中危淋巴结阴性甲状腺癌的手术治疗:一项单机构研究使用倾向性匹配分析比较甲状腺叶切除术与全甲状腺切除术

Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy.
PubMed 文献 · Thyroid · 2022-01-01

该单机构研究纳入1985至2016年3756例T1T2N0/Nx分化良好的甲状腺癌患者,经倾向性评分匹配后比较918例甲状腺叶切除术与918例全甲状腺切除术患者,两组10年总生存率、疾病特异性生存率和无复发生存率均无显著差异。

要点

  • 倾向性匹配后甲状腺叶切除术与全甲状腺切除术的10年总生存率分别为92.2%和91.3%,无显著差异(p=0.9668)。
  • 两组10年疾病特异性生存率分别为100%和99.1%,无显著差异(p=0.1967)。
  • 两组10年无复发生存率分别为99.5%和98.3%,无显著差异(p=0.079)。

核心结论

  • 对于低/中危甲状腺内小于4厘米的甲状腺癌患者,选择甲状腺叶切除术者的生存结局与接受全甲状腺切除术的可比组相似。

研究设计与样本

  • 单机构研究,分析1985至2016年在该机构接受初次手术的6259例分化良好的甲状腺癌患者数据库,识别出3756例T1T2N0/Nx患者,其中943例接受甲状腺叶切除术、2813例接受全甲状腺切除术。
  • 使用倾向性评分匹配,匹配标准包括年龄、性别、组织学、131I治疗、美国甲状腺协会风险分层和美国癌症联合委员会分期,最终918例甲状腺叶切除术患者与918例全甲状腺切除术患者成功匹配。
  • 采用Pearson χ2检验或Fisher精确检验比较分类协变量,采用Student t检验比较两组连续变量;采用Kaplan-Meier法计算疾病特异性生存率、总生存率和无复发生存率,采用log-rank检验进行比较。

主要发现

  • 倾向性匹配后,甲状腺叶切除术组与全甲状腺切除术组的总生存率无显著差异(10年总生存率:92.2% vs 91.3%,p=0.9668)。
  • 两组疾病特异性生存率无显著差异(10年疾病特异性生存率:100% vs 99.1%,p=0.1967)。
  • 两组无复发生存率无显著差异(10年无复发生存率:99.5% vs 98.3%,p=0.079)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The approach for surgical treatment of patients with low-/intermediate-risk T1T2N0/Nx well-differentiated thyroid cancer (WDTC)-total thyroidectomy (TT) versus thyroid lobectomy (TL)-remains a controversial topic. Conducting a randomized controlled trial (RCT) would be the gold standard to address this issue. However, this is challenging due to excellent survival outcomes, and therefore, high number of patients and long-term follow-up would be required. As an alternative to RCT, we have used propensity score (PS) matching to determine if T1T2N0/Nx patients selected to have TL had equivalent outcomes to a similar group treated with TT. Methods: After institutional review board approval, a database of 6259 patients with WDTC treated with primary surgery at our institution between 1985 and 2016 was analyzed to identify patients with T1T2N0/Nx cancers. Of 3756 patients identified, 943 were managed by TL and 2813 by TT. To control for possible confounders and reduce potential bias, we selected age, sex, histology, 131I therapy, American Thyroid Association risk, and American Joint Committee Cancer stage as our PS matching criteria. Subsequently, 918 TL patients were successfully matched with 918 TT patients. The Pearson χ2 test or Fisher's exact test was used to compare categorical covariates, and Student's t-test was used for comparison of continuous variables between the two groups. Disease-specific survival (DSS), overall survival (OS), and recurrence-free survival (RFS) were calculated using the Kaplan-Meier method and compared using the log-rank test. Results: After PS matching, there were no significant differences between TL and TT patients for OS (10-year OS: 92.2% vs. 91.3%, p = 0.9668), DSS (10-year DSS: 100% vs. 99.1%, p = 0.1967), or RFS (10-year RFS: 99.5% vs. 98.3%, p = 0.079). Conclusions: For low-/intermediate-risk patients with intrathyroidal thyroid cancer <4 cm, patients selected for TL have similar survival outcomes to a comparable group treated by TT.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Matsuura D, Yuan A, Harris V, et al. Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy. Thyroid. 2022. PMID: 34861772. doi:10.1089/thy.2021.0356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。